Mostrando 47,041 - 47,060 Resultados de 48,117 Para Buscar '"Japan"', tiempo de consulta: 0.40s Limitar resultados
  1. 47041
    “…BACKGROUND: The RigiScan(®) is widely used for evaluating impairment of erectile function after traumatic events such as traffic accidents, workplace injuries, and surgical operations, and is often used in preparing diagnostic reports of erectile dysfunction, which can then be used as evidence in court cases. In Japan, the Ministry of Health, Labour and Welfare requires the use of RigiScan(®) monitoring for evaluating nocturnal penile tumescence (NPT) when assessing disability benefits for workplace accidents. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 47042
    “…RESULTS: A total of 35 studies were identified from the United States (n=22), Australia (n=9), Canada (n=2), Japan (n=1), and Germany (n=1) and appraised using the Critical Appraisal Skills Programme (CASP) checklist. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 47043
    “…BACKGROUND: Omarigliptin is a once-weekly (q.w.) oral DPP-4 inhibitor that is approved for the treatment of patients with type 2 diabetes mellitus (T2DM) in Japan. To support approval of omarigliptin in the United States, the clinical development program included a cardiovascular (CV) safety study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 47044
  5. 47045
  6. 47046
    “…METHODS: From July to October in 2015, first MRSA isolate from each patient was collected in Juntendo University Hospital, Tokyo, Japan. MRSA strains were categorized as CA-MRSA and HA-MRSA according to the clinical definition of CDC. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 47047
    “…BACKGROUND: Cefiderocol (S-649266) is a novel siderophore cephalosporin under development by Shionogi (Osaka, Japan). Previous studies have demonstrated cefiderocol efficacy against a diverse population of Gram-negative bacteria with MICs ≤ 4 μg/mL. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 47048
    “…METHODS: From January 2014 to December 2016, we prospectively obtained serum and/or cerebrospinal fluid (CSF) samples from febrile neonates and young infants < 4 months suspecting sepsis and meningoencephalitis in Niigata, Japan. RNA/DNA were extracted from the samples and viral etiologies including HPeV3, EVs, and/or herpes simplex virus were tested using the real-time PCR, followed by genetic sequencing and typing. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 47049
  10. 47050
    “…SETTING: ED of a teaching hospital in Japan. PARTICIPANTS: 12 211 patients with CVD aged ≥18 years who presented to the ED by an ambulance between 1 February 2006 and 30 September 2014 were evaluated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 47051
    “…During the 1950s and 1960s, residents of Minamata bay, Japan were exposed to high concentrations of methyl mercury as the result of ingestion of fish and shellfish that had become contaminated in this infamous environmental disaster. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 47052
  13. 47053
    “…METHODS: The Ministry of Health (MOH) with support from the United States Agency for International Development-funded FUNZOKenya project and MOH/Japan International Cooperation Agency (JICA) project conducted a country-wide training needs assessment (TNA) to identify skill gaps in the provision of specialized health care in private and public hospitals in 46 out of Kenya’s 47 counties between April and June 2015. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 47054
    “…METHODS: We identified patients with locally advanced or metastatic breast cancer, treated with eribulin monotherapy between July 2011 and December 2015 at the National Cancer Center Hospital, Tokyo, Japan. Patients who would have met the following eligibility criteria from the EMBRACE trial were included in the eligible group, and the rest were included in the ineligible group: 1) Eastern Cooperative Oncology Group Performance status 0–2; 2) adequate function of principal organs; and 3) absence of active infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 47055
    “…METHODS: Subjects comprised 1026 men and 952 women between 40 and 79 years old at baseline (1997–2000) who participated in the National Institute for Longevity Sciences - Longitudinal Study of Aging, Japan. ALM (kg) and 5 adjusted indices of ALM (ALM/leg length, ALM/height, ALM/height(2), ALM/weight, and ALM/body mass index [BMI]) were assessed at baseline. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 47056
    “…The clinical data of patients with mCRC who were treated with regorafenib or TFTD and those of drug‐naive patients, between June 2014 and September 2015, were retrospectively collected from 24 institutions in Japan. Overall survival (OS) was evaluated using the Cox's proportional hazard models based on propensity score adjustment for baseline characteristics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 47057
  18. 47058
  19. 47059
  20. 47060
Herramientas de búsqueda: RSS